No Data
No Data
Pancreatic Cancer on the Rise: How Biotech Firms Are Developing Groundbreaking Treatments
After looking at public health records for 3.8 million patients with invasive spreading cancer, researchers recently discovered that Generation X may ...
Biotech Advances in 2024: Innovative Treatments Aim to Boost Pancreatic Cancer Survival Rates
USA News Group – Recognized as one of the most lethal cancers, researchers are striving to improve survival rates for pancreatic cancer patients by...
Nektar, Verastem Among Healthcare Additions in Russell Microcap; Assertio, Sangamo Removed
Russell 3000: Inovio, Ocugen Among Healthcare Additions; Assertio, Ginkgo Bioworks Among Deletions
Verastem Is Maintained at Buy by Alliance Global Partners
Verastem Is Maintained at Buy by Alliance Global Partners
Express News | Alliance Global Partners Maintains Buy on Verastem, Lowers Price Target to $20
No Data
Brahman : me as well
R30ROP Brahman: Rarely any comments on this stock. Felt like a lonely bagholder![grimacing 😬](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f62c.png)
Meoww R30ROP: Owh me a bag holder lol !!!
R30ROP : So grateful it is moving. Just when I thought we hit ATL it dropped to another new low!
R30ROP Meoww: We’ll get there.![pray 🙏](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f64f-1f3fd.png)